Mark Rijpkema

894 total citations
24 papers, 616 citations indexed

About

Mark Rijpkema is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Mark Rijpkema has authored 24 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Rheumatology. Recurrent topics in Mark Rijpkema's work include MRI in cancer diagnosis (9 papers), Advanced MRI Techniques and Applications (8 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Mark Rijpkema is often cited by papers focused on MRI in cancer diagnosis (9 papers), Advanced MRI Techniques and Applications (8 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Mark Rijpkema collaborates with scholars based in Netherlands, United Kingdom and Germany. Mark Rijpkema's co-authors include Arend Heerschap, Jelle O. Barentsz, Albert J. van der Kogel, Johannes H.A.M. Kaanders, F.B.M. Joosten, Ferdinand A. van Dorsten, Marinette van der Graaf, Jean de la Rosette, Marc Engelbrecht and A.A.J. Verhofstad and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and The Journal of Urology.

In The Last Decade

Mark Rijpkema

23 papers receiving 611 citations

Peers

Countries citing papers authored by Mark Rijpkema

Since Specialization

Citations

This map shows the geographic impact of Mark Rijpkema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Rijpkema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Rijpkema more than expected).

Fields of papers citing papers by Mark Rijpkema

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Rijpkema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Rijpkema. The network helps show where Mark Rijpkema may publish in the future.

Co-authorship network of co-authors of Mark Rijpkema

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Rijpkema. A scholar is included among the top collaborators of Mark Rijpkema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Rijpkema. Mark Rijpkema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prostate-Specific Membrane Antigen–Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial 2024 ·Journal of Nuclear Medicine ·Melline G.M. Schilham, Diederik M. Somford, Heidi V.N. Küsters‐Vandevelde, Rick Hermsen, (unknown), (unknown), Tom W. J. Scheenen, Martin Gotthardt, J.P. Michiel Sedelaar, Mark Rijpkema	14
2	Harnessing the Power of Radiation to Battle Cancer 2024 ·Frontiers for Young Minds ·(unknown), (unknown), Sandra Heskamp, Mark Rijpkema, Sanne A. M. van Lith	0
3	Subnodal Correspondence of PSMA Expression and USPIO-MRI in Metastatic Pelvic Lymph Nodes in Prostate Cancer 2023 ·Investigative Radiology ·(unknown), Diederik M. Somford, Andor Veltien, Patrik Zámecnik, Jelle O. Barentsz, J.P. Michiel Sedelaar, Heidi V.N. Küsters‐Vandevelde, Martin Gotthardt, Mark Rijpkema, Tom W. J. Scheenen	3
4	How Image-Guided Pathology Can Improve the Detection of Lymph Node Metastases in Prostate Cancer 2022 ·Clinical Nuclear Medicine ·Melline G.M. Schilham, Heidi V.N. Küsters‐Vandevelde, Diederik M. Somford, Mark Rijpkema, Martin Gotthardt	2
5	Head-to-Head Comparison of ⁶⁸Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients 2021 ·Journal of Nuclear Medicine ·Melline G.M. Schilham, Patrik Zámecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom W. J. Scheenen, Jelle O. Barentsz, James Nagarajah, Martin Gotthardt	28
6	Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging 2020 ·Molecular Diagnosis & Therapy ·(unknown), Mark Rijpkema, Tessa J.J. de Bitter, (unknown), Cornelis F.M. Sier, Sophie Hernot, Gooitzen M. van Dam, Irıs D. Nagtegaal, Bastiaan Klarenbeek, Camiel Rosman, Rachel S. van der Post	12
7	Multimodal fluorescence-guided surgery of colorectal peritoneal metastases, a phase I/II clinical trial. 2020 ·Journal of Clinical Oncology ·(unknown), (unknown), André J. A. Bremers, Otto C. Boerman, Mark Rijpkema, Johannes H.W. de Wilt	1
8	Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study 2018 ·Theranostics ·Marlène C.H. Hekman, Mark Rijpkema, Stijn Muselaers, Egbert Oosterwijk, Christina A. Hulsbergen‐van de Kaa, Otto C. Boerman, Wim J.G. Oyen, Johan F. Langenhuijsen, Peter F.A. Mulders	93
9	Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250 2015 ·The Journal of Urology ·Stijn Muselaers, Mark Rijpkema, Desirée L. Bos, Johan F. Langenhuijsen, Wim J.G. Oyen, Peter F.A. Mulders, Egbert Oosterwijk, Otto C. Boerman	20
10	Radiolabeled Imaging Probes Targeting Angiogenesis for Personalized Medicine 2013 ·Current Pharmaceutical Design ·Samantha Y.A. Terry, Mark Rijpkema, K. Abiraj, Winette T.A. van der Graaf, Wim J.G. Oyen, Otto C. Boerman	4
11	Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma 2008 ·Oral Oncology ·Ellen M. Van Cann, Mark Rijpkema, Arend Heerschap, Andries van der Bilt, R. Koole, Paul J.W. Stoelinga	27
12	Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium‐DTPA‐enhanced MRI and localized ¹⁹F MRS pharmacokinetic studies of 5‐fluorouracil 2006 ·NMR in Biomedicine ·Hanneke W.M. van Laarhoven, Dennis W. J. Klomp, Mark Rijpkema, (unknown), D. J. Th. Wagener, Jelle O. Barentsz, Cornelis J.A. Punt, Arend Heerschap	42
13	Gadopentetate Dimeglumine and FDG Uptake in Liver Metastases of Colorectal Carcinoma as Determined with MR Imaging and PET 2005 ·Radiology ·Hanneke W.M. van Laarhoven, Lioe‐Fee de Geus‐Oei, Bastiaan Wiering, Jasper Lok, Mark Rijpkema, J.H.A.M. Kaanders, Paul F. M. Krabbe, Theo J. M. Ruers, Cornelis J.A. Punt, Albert J. van der Kogel, Wim J.G. Oyen, Arend Heerschap	11
14	BOLD MRI response to hypercapnic hyperoxia in patients with meningiomas: correlation with Gadolinium-DTPA uptake rate 2004 ·Magnetic Resonance Imaging ·Mark Rijpkema, Janneke Schuuring, (unknown), Hans J.J.A. Bernsen, J.H.A.M. Kaanders, Albert J. van der Kogel, Arend Heerschap	25
15	Combined quantitative dynamic contrast‐enhanced MR imaging and ¹H MR spectroscopic imaging of human prostate cancer 2004 ·Journal of Magnetic Resonance Imaging ·Ferdinand A. van Dorsten, Marinette van der Graaf, Marc Engelbrecht, Geert J.L.H. van Leenders, A.A.J. Verhofstad, Mark Rijpkema, Jean de la Rosette, Jelle O. Barentsz, Arend Heerschap	132
16	Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases 2003 ·Journal of Magnetic Resonance Imaging ·Hanneke W.M. van Laarhoven, Mark Rijpkema, Cornelis J.A. Punt, Theo J. M. Ruers, Jan C.M. Hendriks, Jelle O. Barentsz, Arend Heerschap	37
17	Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging 2002 ·International Journal of Radiation OncologyBiologyPhysics ·Mark Rijpkema, Johannes H.A.M. Kaanders, F.B.M. Joosten, Albert J. van der Kogel, Arend Heerschap	101
18	Effect of Breathing a Hyperoxic Hypercapnic Gas Mixture on the Oxygenation of Meningiomas; Preliminary Results 2002 ·Journal of Neuro-Oncology ·Janneke Schuuring, Mark Rijpkema, Hans J.J.A. Bernsen, (unknown), Richard van der Maazen, Johannes H.A.M. Kaanders, Albert van der Kogel, Arend Heerschap	9
19	Radio-frequency probe for 1H decoupled 31P MRS of the head and neck region 2001 ·Magnetic Resonance Imaging ·Dennis W. J. Klomp, Dave Collins, (unknown), Adam J. Schwarz, Mark Rijpkema, (unknown), (unknown), Martin O. Leach, Arend Heerschap	16
20	SAR and tissue heating with a clinical31P MRS protocol using surface coils, adiabatic pulses, and proton-decoupling 2000 ·Magnetic Resonance in Medicine ·Adam J. Schwarz, Mark Rijpkema, David J. Collins, Geoffrey S. Payne, (unknown), (unknown), Arend Heerschap, Martin O. Leach	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact